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tumor growth in the presence of insulin analogs [5]. Thus, gain-
ing confirmative data through a simple comparison between 
the presence and the absence of diabetics for estimating a prog-
nosis for the disease is extremely difficult because it is hard to 
control so many kinds of biases. Furthermore, the reliability of 
the results is quite low because the number in the observation 
group was relatively small (67) compared with that in the con-
trol group (590) in this study. Therefore, a population-based 
prospective cohort study, rather than a case-control study, is 
needed to yield data in which one can have more confidence.
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According to a recent cohort study, diabetic patients had a sig-
nificantly greater risk of colorectal cancer (CRC) than non-dia-
betic patients [1]. This study went one-step further and analyzed 
the postoperative survival difference between diabetic and non-
diabetic patients with comorbid colorectal cancer. The authors 
found that no relationship existed between the presence of dia-
betes and the recurrence of or the survival rate for colorectal 
cancer. However, many other studies have reported that diabe-
tes significantly and negatively impacts overall survival (OS) 
and that the cancer-specific survival (CSS) and prognostic im-
pact of diabetes on OS and CSS were particularly significant in 
patients with stage II colon cancer [2]. However, many articles 
report results different from what we know. For instance, in 
patients undergoing colorectal cancer surgery, those with dia-
betes had a 23% lower in hospital mortality and fewer postop-
erative complications compared to those without diabetics [3], 
but the reason for this finding is uncertain. 
There are many factors affecting the result of this study. An 
important bias is smoking. The association with colorectal can-
cer risk was significantly modified by smoking status [1]. Even 
though the presence of diabetes did not affect the overall sur-
vival in patients diagnosed with CRC, the quality of diabetes 
care prior to CRC diagnosis, which persisted after diagnosis, 
may have moderated the mortality in patients with diabetes 
[4]. Insulin itself, particularly insulin glargine, may play more 
of a mitogenic than a carcinogenic role in association with dif-
ferent types of cancer, suggesting an amplified rate of existing 
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